FDA NDC Directory · JSON-LD · Markdown

Lubiprostone

NDC 70771-1763 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerZydus Lifesciences Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA214131
Dosage form / routeCAPSULE · ORAL
Active ingredientsLUBIPROSTONE (8 ug/1)
Marketing started20230323
Package count2

External sources

Source: openFDA. Public-domain (CC0).